Lv51
1200 积分 2022-09-09 加入
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
7小时前
待确认
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
8天前
已完结
Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: A meta-analysis of placebo-controlled randomized trials
8天前
已完结
Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians
8天前
已完结
Diabetes: Insulin plus metformin for T2DM—are there benefits?
20天前
已完结
Orforglipron in type 2 diabetes mellitus and obesity: an overview
1个月前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
1个月前
已完结
Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement
2个月前
已完结
American Association of Clinical Endocrinology Consensus Statement
6个月前
已完结
Evaluation and Management of Thyroid Nodules: A Joint Consensus Statement From the British Thyroid Association (BTA), British Association of Endocrine and Thyroid Surgeons (BAETS) and Collaborating Bodies
7个月前
已完结
皖公网安备34019202002308
